Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy
Public ClinicalTrials.gov record NCT00676650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the safety and efficacy of sunitinib in combination with prednisone versus placebo and prednisone in patients that have metastatic castration-resistant prostate cancer that has progressed after treatment with a docetaxel-containing chemotherapy regimen. This is a second-line study.
Study identification
- NCT ID
- NCT00676650
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 873 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2008 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Mar 8, 2013
2008 – 2011
United States locations
- U.S. sites
- 87
- U.S. states
- 24
- U.S. cities
- 76
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Decatur | Alabama | 35601 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35805 | — |
| Pfizer Investigational Site | Anaheim | California | 92801 | — |
| Pfizer Investigational Site | Encinitas | California | 92024 | — |
| Pfizer Investigational Site | Glendale | California | 91206 | — |
| Pfizer Investigational Site | La Jolla | California | 92037 | — |
| Pfizer Investigational Site | Los Angeles | California | 90033 | — |
| Pfizer Investigational Site | Modesto | California | 95355 | — |
| Pfizer Investigational Site | Thousand Oaks | California | 91360 | — |
| Pfizer Investigational Site | Thousands Oaks | California | 91360 | — |
| Pfizer Investigational Site | Vista | California | 92083 | — |
| Pfizer Investigational Site | Westlake Village | California | 91361 | — |
| Pfizer Investigational Site | Denver | Colorado | 80205 | — |
| Pfizer Investigational Site | Lafayette | Colorado | 80025 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32605 | — |
| Pfizer Investigational Site | Orlando | Florida | 32806 | — |
| Pfizer Investigational Site | Winter Park | Florida | 32789 | — |
| Pfizer Investigational Site | Arlington Heights | Illinois | 60005 | — |
| Pfizer Investigational Site | Niles | Illinois | 60714 | — |
| Pfizer Investigational Site | Winfield | Illinois | 60190 | — |
| Pfizer Investigational Site | Zion | Illinois | 60099 | — |
| Pfizer Investigational Site | Carmel | Indiana | 46032 | — |
| Pfizer Investigational Site | Fishers | Indiana | 46037 | — |
| Pfizer Investigational Site | Greenfield | Indiana | 46140 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46219 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46227 | — |
| Pfizer Investigational Site | Lafayette | Indiana | 47905 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02114 | — |
| Pfizer Investigational Site | Danvers | Massachusetts | 01923 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55455 | — |
| Pfizer Investigational Site | Saint Cloud | Minnesota | 56303-5000 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Southaven | Mississippi | 38671 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68506 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68114 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89052 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89074 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89128 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89148 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89169 | — |
| Pfizer Investigational Site | Sewell | New Jersey | 08080 | — |
| Pfizer Investigational Site | New York | New York | 10032 | — |
| Pfizer Investigational Site | The Bronx | New York | 10461 | — |
| Pfizer Investigational Site | The Bronx | New York | 10467-2401 | — |
| Pfizer Investigational Site | Cary | North Carolina | 27518 | — |
| Pfizer Investigational Site | Durham | North Carolina | 27710 | — |
| Pfizer Investigational Site | Kernersville | North Carolina | 27284 | — |
| Pfizer Investigational Site | Lexington | North Carolina | 27295 | — |
| Pfizer Investigational Site | Mount Airy | North Carolina | 27030 | — |
| Pfizer Investigational Site | North Wilkesboro | North Carolina | 28659 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27607 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27614 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Bismarck | North Dakota | 58501 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44106 | — |
| Pfizer Investigational Site | Mayfield Heights | Ohio | 44124 | — |
| Pfizer Investigational Site | Mentor | Ohio | 44060 | — |
| Pfizer Investigational Site | Orange | Ohio | 44122 | — |
| Pfizer Investigational Site | Westlake | Ohio | 44145 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97401 | — |
| Pfizer Investigational Site | Springfield | Oregon | 97477 | — |
| Pfizer Investigational Site | Clairton | Pennsylvania | 15025 | — |
| Pfizer Investigational Site | Greensburg | Pennsylvania | 15601 | — |
| Pfizer Investigational Site | Johnstown | Pennsylvania | 15901 | — |
| Pfizer Investigational Site | Kingston | Pennsylvania | 18704 | — |
| Pfizer Investigational Site | Lancaster | Pennsylvania | 17604 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15215 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15232 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15237 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15241 | — |
| Pfizer Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| Pfizer Investigational Site | Wexford | Pennsylvania | 15090 | — |
| Pfizer Investigational Site | Brighton | Tennessee | 38011 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38104 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Arlington | Texas | 76014 | — |
| Pfizer Investigational Site | Dallas | Texas | 75246 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76177 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Webster | Texas | 77598 | — |
| Pfizer Investigational Site | Everett | Washington | 98201 | — |
| Pfizer Investigational Site | Monroe | Washington | 98272 | — |
| Pfizer Investigational Site | Seattle | Washington | 98101 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 118 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00676650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2013 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00676650 live on ClinicalTrials.gov.